I-API NT
| CAS NO. | Igama lomkhiqizo |
| 26159-34-2 | i-naproxen sodium |
| 96829-58-2 | I-Orlistat |
| 103-90-2 | I-Paracetamol |
| 107133-36-8 | perindopril erbumine |
| I-Potassium Clavulanate Avicel Blend 1: 1 | |
| I-Potassium Clavulanate Syloid Blend 1: 1 | |
| 147098-20-2 | I-Rosuvastatin Calcium |
| 28523-86-6 | sevoflurane |
| 79902-63-9 | simvastatin |
| 654671-77-9 | I-Sitagliptin phosphate monohydrate |
| 64058-48-6 | I-Spectinomycin sulfate tetrahydrate |
| 54182-58-0 | I-Sucralfate |
| 38194-50-2 | sulindac |
| 54965-24-1 | i-tamoxifen citrate |
| 302-79-4 | I-Tretinoin |
| Isibizo | Ifomula Yamamolekhula | Isisindo Semolekyuli | PSA | I-LogP | Inombolo ye-MDL | Ukubukeka & Isimo Somzimba | Ubuningi | Indawo yokubilisa | Indawo Yokuncibilika | I-Flash Point | Inkomba Yokukhombisa | Isimo Sesitoreji | Ama-RTECS | Izitatimende Zokuphepha | Ikhodi ye-HS | Izitatimende Zobungozi | Amakhodi Ayingozi |
| i-sodium (S) -2- (6-methoxynaphthalen-2-yl) propanoate; Anaprox, Naprelan; (S) -Naproxen Sodium Usawoti; I-sodium yeNaproxen; | C14H13NaO3 | 252.24100 | 49.36000 | 1.70180 | impuphu emhlophe | 403.9ºC ku-760 mmHg | 250-251ºC | 154.5ºC | QJ1047000 | 2918990090 | R22 | Xn | |||||
| [(2S) -1 - [(2S, 3S) -3-hexyl-4-oxooxetan-2-yl] tridecan-2-yl] (2S) -2-formamido-4-methylpentanoate; (S) - (( S) -1 - ((2S, 3S) -3-Hexyl-4-oxooxetan-2-yl) tridecan-2-yl) 2-formamido-4-methylpentanoate; tetrahydrolipstatin; Alli; Orlipastat; Orlipastatum; Xenical; THLP; | C29H53NO5 | 495.73500 | 81.70000 | 7.90870 | Impuphu emhlophe yekristalu | 0.976 g / cm3 | 615.9ºC ku-760 mmHg | <50ºC | 326.3ºC | 1.469 | 2-8ºC | OH3167600 | |||||
| I-Panex; 4-Acetamidophenol; Acetamide, N- (4-hydroxyphenyl) -; Paracetamol; 4'-Hydroxyacetanilide; NAPAP; N- (4-Hydroxyphenyl) acetamide; Exdol; Acetaminophen; Korum; G 1; Dypap; N- (4) -hydroxyphenyl) ethanamide; I-Hedex; I-Dirox; I-APAP; I-Fevor; | C8H9NO2 | 151.16300 | 49.33000 | 1.42360 | UMFCD00002328 | Okuqinile Okumhlophe | 1,293 g / cm3 | 168-172 ° C (kuvuliwe) | AE4200000 | S26; S36; S61; S37 / 39 | 29242930 | R22; R36 / 37/38; R52 / 53; R36 / 38; R40 | Xn | ||||
| Aceon; Perindopril tert-butylamine; PrestariuM; Perindopril t-Butylamine Usawoti; Unii-1964X464oj; Perinodpril ErbiMune; ButylaMiniperindopril; Perinodopril; Perindopril Erbumine; CoversuM; Perindoril; | C19H32N2O5.C4H11N | 441.60500 | 121.96000 | 3.71330 | UMFCD02313824 | okuqinile okumhlophe | 1.15 g / cm3 | 537.4ºC ku-760mmHg | 126-128ºC | 278.8ºC | S26; S36 | R36 / 37/38 | Xi | ||||
| (3R, 5S, 6E) -7- [4- (4-Fluorophenyl) -6- (1-methylethyl) -2- [methyl (methylsulfonyl) amino] -5-pyrimidinyl] -3,5-dihydroxy-6- i-heptenoic Acid Calcium Salt; Rosuvastatin Calcium Salt; Rosuvastatin Hemicalcium; Rostar; ZD 4522 Calcium Salt; S 4522; Fortius; Crestor; | 2 (C22H27FN3O6S) .Ca; C44H54CaF2N6O12S2 | 1001.14000 | 304.26000 | 4.29560 | Okumhlophe kuya ku-Off-White Crystalline Solid | 745.6ºC ku-760 mmHg | 122ºC | 404.7ºC | 2935009090 | ||||||||
| Ubuningi; Sevoflurane; Sevofrane; RE 347; mr6s4; 1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy) propane; FluoroMethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether; 347mmzEbg; i-fluoromethyl 1,1,1,3,3,3-hexafluoro-2-propyl ether; i-Ultane; | C4H3F7O | 200.05500 | 9.23000 | 2.42320 | I-MFCD00153189 | Amafutha angenambala | 1.505 | 49.5ºC ku-760 mmHg | 50-60ºC | 58ºC | 1.266 | Isiqandisi | KO0737000 | 26-36 / 37/39 | R36 / 37/38 | Xi | |
| Simcor; Eucor; Lipex; Simvastatin; Denan; Lipovas; ZOCOR; simvasterol; Zocord; Rechol; | C25H38O5 | 418.56600 | 72.83000 | 4.58560 | okumhlophe kuphume- powder omhlophe wamakristalu | 1.11 g / cm3 | 564.9ºC ku-760 mmHg | 139ºC | 184.8ºC | 1.53 | 0-6ºC | EK7798000 | S26; S36 | R36 / 37/38 | Xi | ||
| I-Sitagliptin phosphate hydrate (jan); 7 - [(3R) -3-Amino-1-oxo-4- (2,4,5-trifluorophenyl) Butyl] -5,6,7,8-tetrahydro-3- (trifluoromethyl ) -1,2,4-triazolo [4,3-a] pyrazinephosphatemonohydrate; 3 (R) -3-amino-1- [3- (trifluoromethyl) -5H, 6H, 7H, 8H [1,2,4] i-triazolo [4,3-a] pyrazin-7-yl] -4- (2,4,5-trifluorophenyl) butan-1-one phosphate monohydrate; I-Sitagliptin phosphate yocwaningo; I-Sitagliptin phosphate hydrate; (2R) -4-oxo -4- [3- (trifluoromethyl) -5,6-dihydro [1,2,4] triazolo [4,3-a] pyrazin-7 (8H) -yl] -1- (2,4,5-trifluorophenyl ) i-butan-2-amine dihydrogenphosphate monohydrate; I-Sitagliptin phosphate (usan); uJanuvia (tn); iSitagliptin monohydrate; | C16H15F6N5O.H3PO4.H2O | 523.32400 | 173.84000 | 1.66180 | I-powder emhlophe noma ecishe ibe mhlophe | 529.9ºC ku-760 mmHg | 274.3ºC | 2933990090 | |||||||||
| SPECTINOMYCIN SULPHATE; Trobicin sulfate; SpectinoMycin sulphate tetrahydrate CGMP / FDA; SPECTINOMYCINHCL; Actinospectacin, tetrahydrate, sulfate; Spectinomycin sulphate; Spectinomycin, tetrahydrate, sulfate; | I-C14H24N2O7.H2SO4.4 (H2O) | 486.49000 | 229.18000 | -1.29300 | Ikristalu elimhlophe | 583.1ºC ku-760 mmHg | |||||||||||
| I-Keal; i-carafate; i-Ulcar; i-Citogel; i-Sugast; i-Succosa; i-Venter; i-ulcerban; i-Sucrate; i-Urbal; | I-C12H30Al8O51S8.8 (H3AlO3) | 2088.84000 | 1435.37000 | 1435.370 | Impuphu emhlophe emhlophe. | 2-8ºC | |||||||||||
| I-AFLODAC; Imbaral; Saldac; SULREUMA; Sudac; (Z) -2- (3- (4- (methylsulfinyl) benzylidene) -6-fluoro-2-methyl-3H-inden-1-yl) i-acetic acid; I-Aclin; i-ReuMyl ; SULINOL; mobilin; Clinoril, Aflodac, Sulreuma; Sulindac; MK-231; (Z) -2- (5-Fluoro-2-methyl-1- (4- (methylsulfinyl) benzylidene) -1H-inden-3-yl i-acetic acid; (Z) -5-Fluoro-2-methyl-1- [p- (methylsulfinyl) benzylidene] indene-3-acetic acid; | C20H17FO3S | 356.41100 | 73.58000 | 5.23120 | Okuqinile okuphuzi. | 1.38 g / cm3 | 581.6ºC ku-760 mmHg | 182-185ºC | 305.6ºC | 1.672 | Gcina kuvaliwe ngokuqinile. | NK8226000 | 2930909090 | R22 | Xn | ||
| Usawoti we-Tamoxifen citrate; | C26H29NO.C6H8O7 | 563.63800 | 144.6000 | 4.74760 | I-MFCD00058321 | omhlophe kuya kumpuphu omhlophe | 665.9ºC ku-760 mmHg | 140-144ºC | 356.5ºC | 2-8ºC | IKH2387000 | I-S45-S53 | 2922199090 | R22; R45 | T | ||
| 2E, 4E, 6E, 8E) -3,7-Dimethyl-9- (2,6,6-trimethylcyclohex-1-en-1-yl) nona-2,4,6,8-tetraenoic acid; i-retin-a ; I-ATRA; I-13-cis-retinoic acid; i-aknoten; konke okudlulisa-3,7-Dimethyl-9- (2,6,6-trimethyl-1-cyclohexen-1-yl) -2,4,6,8- nonatetraenoic Acid; Tretinoin; [3H] -Retinoic Acid; 13-trans-Retinoic acid; Atragen; effederm; (all-e); all-trans-Retinoic Acid; Vitamin A Acid; aberel; eudyna; I-Retinoic acid; i-tretinoin; i-all-trans-vitamin A acid; i-tretinm; i-trans-retinoic acid yonke | C20H28O2 | 300.43500 | 37.30000 | 5.60260 | UMFCD00001551 | Uphuzi ophuzi ophuzi | 1.011 g / cm3 | 462.8ºC ku-760 mmHg | 179-184ºC | 350.6ºC | I-S36 / 37-S45 | 2916209090 | R22; R38; R63 | Xn |
| CAS NO. | Igama lomkhiqizo | Isibizo | Ifomula Yamamolekhula | Isisindo Semolekyuli | PSA | I-LogP | Inombolo ye-MDL | Ukubukeka & Isimo Somzimba | Ubuningi | Indawo yokubilisa | Indawo Yokuncibilika | I-Flash Point | Inkomba Yokukhombisa | Isimo Sesitoreji | Ama-RTECS | Izitatimende Zokuphepha | Ikhodi ye-HS | Izitatimende Zobungozi | Amakhodi Ayingozi |
| 26159-34-2 | i-naproxen sodium | i-sodium (S) -2- (6-methoxynaphthalen-2-yl) propanoate; Anaprox, Naprelan; (S) -Naproxen Sodium Usawoti; I-sodium yeNaproxen; | C14H13NaO3 | 252.24100 | 49.36000 | 1.70180 | impuphu emhlophe | 403.9ºC ku-760 mmHg | 250-251ºC | 154.5ºC | QJ1047000 | 2918990090 | R22 | Xn | |||||
| 96829-58-2 | I-Orlistat | [(2S) -1 - [(2S, 3S) -3-hexyl-4-oxooxetan-2-yl] tridecan-2-yl] (2S) -2-formamido-4-methylpentanoate; (S) - (( S) -1 - ((2S, 3S) -3-Hexyl-4-oxooxetan-2-yl) tridecan-2-yl) 2-formamido-4-methylpentanoate; tetrahydrolipstatin; Alli; Orlipastat; Orlipastatum; Xenical; THLP; | C29H53NO5 | 495.73500 | 81.70000 | 7.90870 | Impuphu emhlophe yekristalu | 0.976 g / cm3 | 615.9ºC ku-760 mmHg | <50ºC | 326.3ºC | 1.469 | 2-8ºC | OH3167600 | |||||
| 103-90-2 | I-Paracetamol | I-Panex; 4-Acetamidophenol; Acetamide, N- (4-hydroxyphenyl) -; Paracetamol; 4'-Hydroxyacetanilide; NAPAP; N- (4-Hydroxyphenyl) acetamide; Exdol; Acetaminophen; Korum; G 1; Dypap; N- (4) -hydroxyphenyl) ethanamide; I-Hedex; I-Dirox; I-APAP; I-Fevor; | C8H9NO2 | 151.16300 | 49.33000 | 1.42360 | UMFCD00002328 | Okuqinile Okumhlophe | 1,293 g / cm3 | 168-172 ° C (kuvuliwe) | AE4200000 | S26; S36; S61; S37 / 39 | 29242930 | R22; R36 / 37/38; R52 / 53; R36 / 38; R40 | Xn | ||||
| 107133-36-8 | perindopril erbumine | Aceon; Perindopril tert-butylamine; PrestariuM; Perindopril t-Butylamine Usawoti; Unii-1964X464oj; Perinodpril ErbiMune; ButylaMiniperindopril; Perinodopril; Perindopril Erbumine; CoversuM; Perindoril; | C19H32N2O5.C4H11N | 441.60500 | 121.96000 | 3.71330 | UMFCD02313824 | okuqinile okumhlophe | 1.15 g / cm3 | 537.4ºC ku-760mmHg | 126-128ºC | 278.8ºC | S26; S36 | R36 / 37/38 | Xi | ||||
| I-Potassium Clavulanate Avicel Blend 1: 1 | |||||||||||||||||||
| I-Potassium Clavulanate Syloid Blend 1: 1 | |||||||||||||||||||
| 147098-20-2 | I-Rosuvastatin Calcium | (3R, 5S, 6E) -7- [4- (4-Fluorophenyl) -6- (1-methylethyl) -2- [methyl (methylsulfonyl) amino] -5-pyrimidinyl] -3,5-dihydroxy-6- i-heptenoic Acid Calcium Salt; Rosuvastatin Calcium Salt; Rosuvastatin Hemicalcium; Rostar; ZD 4522 Calcium Salt; S 4522; Fortius; Crestor; | 2 (C22H27FN3O6S) .Ca; C44H54CaF2N6O12S2 | 1001.14000 | 304.26000 | 4.29560 | Okumhlophe kuya ku-Off-White Crystalline Solid | 745.6ºC ku-760 mmHg | 122ºC | 404.7ºC | 2935009090 | ||||||||
| 28523-86-6 | sevoflurane | Ubuningi; Sevoflurane; Sevofrane; RE 347; mr6s4; 1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy) propane; FluoroMethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether; 347mmzEbg; i-fluoromethyl 1,1,1,3,3,3-hexafluoro-2-propyl ether; i-Ultane; | C4H3F7O | 200.05500 | 9.23000 | 2.42320 | I-MFCD00153189 | Amafutha angenambala | 1.505 | 49.5ºC ku-760 mmHg | 50-60ºC | 58ºC | 1.266 | Isiqandisi | KO0737000 | 26-36 / 37/39 | R36 / 37/38 | Xi | |
| 79902-63-9 | simvastatin | Simcor; Eucor; Lipex; Simvastatin; Denan; Lipovas; ZOCOR; simvasterol; Zocord; Rechol; | C25H38O5 | 418.56600 | 72.83000 | 4.58560 | okumhlophe kuphume- powder omhlophe wamakristalu | 1.11 g / cm3 | 564.9ºC ku-760 mmHg | 139ºC | 184.8ºC | 1.53 | 0-6ºC | EK7798000 | S26; S36 | R36 / 37/38 | Xi | ||
| 654671-77-9 | I-Sitagliptin phosphate monohydrate | I-Sitagliptin phosphate hydrate (jan); 7 - [(3R) -3-Amino-1-oxo-4- (2,4,5-trifluorophenyl) Butyl] -5,6,7,8-tetrahydro-3- (trifluoromethyl ) -1,2,4-triazolo [4,3-a] pyrazinephosphatemonohydrate; 3 (R) -3-amino-1- [3- (trifluoromethyl) -5H, 6H, 7H, 8H [1,2,4] i-triazolo [4,3-a] pyrazin-7-yl] -4- (2,4,5-trifluorophenyl) butan-1-one phosphate monohydrate; I-Sitagliptin phosphate yocwaningo; I-Sitagliptin phosphate hydrate; (2R) -4-oxo -4- [3- (trifluoromethyl) -5,6-dihydro [1,2,4] triazolo [4,3-a] pyrazin-7 (8H) -yl] -1- (2,4,5-trifluorophenyl ) i-butan-2-amine dihydrogenphosphate monohydrate; I-Sitagliptin phosphate (usan); uJanuvia (tn); iSitagliptin monohydrate; | C16H15F6N5O.H3PO4.H2O | 523.32400 | 173.84000 | 1.66180 | I-powder emhlophe noma ecishe ibe mhlophe | 529.9ºC ku-760 mmHg | 274.3ºC | 2933990090 | |||||||||
| 64058-48-6 | I-Spectinomycin sulfate tetrahydrate | SPECTINOMYCIN SULPHATE; Trobicin sulfate; SpectinoMycin sulphate tetrahydrate CGMP / FDA; SPECTINOMYCINHCL; Actinospectacin, tetrahydrate, sulfate; Spectinomycin sulphate; Spectinomycin, tetrahydrate, sulfate; | I-C14H24N2O7.H2SO4.4 (H2O) | 486.49000 | 229.18000 | -1.29300 | Ikristalu elimhlophe | 583.1ºC ku-760 mmHg | |||||||||||
| 54182-58-0 | I-Sucralfate | I-Keal; i-carafate; i-Ulcar; i-Citogel; i-Sugast; i-Succosa; i-Venter; i-ulcerban; i-Sucrate; i-Urbal; | I-C12H30Al8O51S8.8 (H3AlO3) | 2088.84000 | 1435.37000 | 1435.370 | Impuphu emhlophe emhlophe. | 2-8ºC | |||||||||||
| 38194-50-2 | sulindac | I-AFLODAC; Imbaral; Saldac; SULREUMA; Sudac; (Z) -2- (3- (4- (methylsulfinyl) benzylidene) -6-fluoro-2-methyl-3H-inden-1-yl) i-acetic acid; I-Aclin; i-ReuMyl ; SULINOL; mobilin; Clinoril, Aflodac, Sulreuma; Sulindac; MK-231; (Z) -2- (5-Fluoro-2-methyl-1- (4- (methylsulfinyl) benzylidene) -1H-inden-3-yl i-acetic acid; (Z) -5-Fluoro-2-methyl-1- [p- (methylsulfinyl) benzylidene] indene-3-acetic acid; | C20H17FO3S | 356.41100 | 73.58000 | 5.23120 | Okuqinile okuphuzi. | 1.38 g / cm3 | 581.6ºC ku-760 mmHg | 182-185ºC | 305.6ºC | 1.672 | Gcina kuvaliwe ngokuqinile. | NK8226000 | 2930909090 | R22 | Xn | ||
| 54965-24-1 | i-tamoxifen citrate | Usawoti we-Tamoxifen citrate; | C26H29NO.C6H8O7 | 563.63800 | 144.6000 | 4.74760 | I-MFCD00058321 | omhlophe kuya kumpuphu omhlophe | 665.9ºC ku-760 mmHg | 140-144ºC | 356.5ºC | 2-8ºC | IKH2387000 | I-S45-S53 | 2922199090 | R22; R45 | T | ||
| 302-79-4 | I-Tretinoin | 2E, 4E, 6E, 8E) -3,7-Dimethyl-9- (2,6,6-trimethylcyclohex-1-en-1-yl) nona-2,4,6,8-tetraenoic acid; i-retin-a ; I-ATRA; I-13-cis-retinoic acid; i-aknoten; konke okudlulisa-3,7-Dimethyl-9- (2,6,6-trimethyl-1-cyclohexen-1-yl) -2,4,6,8- nonatetraenoic Acid; Tretinoin; [3H] -Retinoic Acid; 13-trans-Retinoic acid; Atragen; effederm; (all-e); all-trans-Retinoic Acid; Vitamin A Acid; aberel; eudyna; I-Retinoic acid; i-tretinoin; i-all-trans-vitamin A acid; i-tretinm; i-trans-retinoic acid yonke | C20H28O2 | 300.43500 | 37.30000 | 5.60260 | UMFCD00001551 | Uphuzi ophuzi ophuzi | 1.011 g / cm3 | 462.8ºC ku-760 mmHg | 179-184ºC | 350.6ºC | I-S36 / 37-S45 | 2916209090 | R22; R38; R63 | Xn |
Bhala umyalezo wakho lapha bese uwuthumela kithi
